top of page

Personalized Immunotherapies for Cancer

Our Mission

 

Achieve Durable Recurrence-Free Immunity from Cancer

At Pyrojas, we are redefining cancer treatment by empowering the immune system to recognize and eliminate tumors with unparalleled precision, driving life-changing outcomes for patients worldwide.

Decades of Recurrence-free Survival

Team

Screenshot 2025-02-21 at 1.53_edited.jpg

Archis Bagati, PhD

  • LinkedIn

Founder & CEO

Screenshot 2025-02-21 at 2.32_edited.jpg

Padmanee Sharma MD/PhD

  • LinkedIn

Advisor - Clinical Oncologist

Screenshot 2025-02-21 at 4_edited.jpg

Nitin Sood

  • LinkedIn

Advisor, Commercial

mo-curtis-new_edited_edited.jpg

Curtis Mo, JD

  • LinkedIn

Corporate, Secretary

Screenshot 2025-02-21 at 2.33_edited.jpg

James P. Allison, PhD

  • LinkedIn

Advisor, Immunology, 2018 Nobel Prize

Screenshot 2025-02-21 at 2.21_edited.jpg

Minesh Mehta, MD

  • LinkedIn

Advisor, Clinical Oncologist

Screenshot 2025-02-21 at 2.21_edited.jpg

John M. Kirkwood, MD

  • LinkedIn

Advisor, Clinical Oncologist

ai-image-779557-1728974016_edited_edited.jpg

Lisa Haile, PhD/JD

  • LinkedIn

Immunology, Intellectual Property 

Investors and Partners

©2025 by PyrOjas Corporation | All Rights Reserved

bottom of page